Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Jaguar's recently completed pivotal effectiveness study of crofelemer for the treatment of CID in dogs demonstrates ...

Jaguar Animal Health Signs New Crofelemer Supply Agreement

Detailed price information for Jaguar Health Inc (JAGX-Q) from The Globe and Mail including charting and trades.
The Wall Street Transcript

Lisa Conte, Jaguar Health (NASD: JAGX) CEO, Details Veterinary and Human Potential for Her New Drug Discovery

Lisa Conte is the founder, president and chief executive officer, and a member of the board of directors, of Jaguar Health, a commercial-stage pharmaceuticals company committed to discovering, ...

Jaguar Animal Health Converts Series O Preferred to Common

Detailed price information for Jaguar Health Inc (JAGX-Q) from The Globe and Mail including charting and trades.